RO-7565020
N/A
Report date: 2025/03/19 16:06:41
Base Information
Drug NameRO-7565020
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[10]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesF. Hoffmann-La Roche Ag
China Registration ClassN/A
Develop Information
Active CompaniesRoche R&D Center (China) LtdF. Hoffmann-La Roche Ltd
Inactive CompaniesF. Hoffmann-La Roche Ag
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A